What is the recommended evaluation and management for a patient with a known atrial septal defect who now presents with aortic regurgitation?

Management of Aortic Regurgitation in a Patient with History of Atrial Septal Defect

For a patient with known ASD who presents with aortic regurgitation, immediately evaluate whether the AR is related to a ventricular septal defect (VSD) with aortic cusp prolapse rather than the ASD itself, as ASDs do not directly cause AR, but concurrent VSDs do.

Critical Initial Assessment

The key diagnostic priority is determining the source and mechanism of the AR:

Rule Out VSD with Aortic Cusp Prolapse

• Small supracristal or perimembranous VSDs cause AR in 6% of cases through prolapse of the aortic valve cusp (usually right coronary cusp) into the defect 1
• This is the most common structural cause linking septal defects to AR
• Perform comprehensive echocardiography to identify any VSD that may have been missed or developed

Confirm ASD Does Not Cause AR

• Multiple studies demonstrate that percutaneous ASD closure does not increase AR incidence or severity 2, 3, 4, 5
• Only 0.6-1.8% of patients develop clinically insignificant increases in AR (trivial to mild) after ASD device closure 2, 3
• The AR is therefore either pre-existing, unrelated to the ASD, or associated with a concurrent VSD

Management Algorithm Based on AR Severity

If Severe AR is Present (Stage C or D):

Proceed with aortic valve surgery according to standard AR guidelines 6:

1. Immediate AVR (Class I indication) if:

   • Patient is symptomatic
   • LVEF <55%
   • Undergoing cardiac surgery for another indication (including ASD/VSD closure)

2. AVR is reasonable (Class IIa) if asymptomatic with:

   • LVEF >55% BUT severe LV enlargement (LVESD >50 mm or indexed LVESD >25 mm/m²)

3. Consider AVR (Class IIb) if:

   • Progressive decline in LVEF to low-normal range (55-60%) on ≥3 serial studies
   • Progressive LV dilation to severe range (LVEDD >65 mm)
   • Low surgical risk

If VSD with AR is Identified:

Close the VSD when AR is progressive to prevent continued worsening and avoid future aortic valve replacement 1:

• Perform VSD closure with concurrent aortic valve repair if AR is moderate
• If AR meets criteria for valve replacement, perform AVR concomitantly with VSD closure 1
• Critical timing principle: Intervene before AR becomes severe enough to require valve replacement 7

Factors predicting need for aortic valve intervention during VSD closure 7:

• Moderate or severe AR
• Small VSD size (paradoxically higher risk)
• Older age at intervention
• More than one cusp prolapse

If Moderate AR is Present:

Perform aortic valve surgery (Class IIa) if undergoing cardiac or aortic surgery for other indications 6, which includes:

• ASD closure (surgical approach)
• VSD closure

If Mild or Less AR:

• Proceed with ASD closure (percutaneous or surgical) without concern for worsening AR 2, 3, 4, 5
• Serial echocardiographic monitoring per standard AR guidelines

Key Clinical Pitfalls to Avoid

1. Do not assume the ASD caused the AR - investigate for VSD or other valvular pathology
2. Do not delay VSD closure if progressive AR is present - early closure prevents need for valve replacement 1
3. Avoid device-to-defect ratio >1.3:1 in ASD closure - correlates with mild AR development (though clinically insignificant) 5
4. Do not perform isolated ASD closure if significant AR from VSD with cusp prolapse exists - address both lesions simultaneously 8

Specific Evaluation Requirements

Obtain comprehensive echocardiography assessing:

• Presence and location of any VSD (especially supracristal/perimembranous)
• Aortic valve cusp prolapse
• AR severity (vena contracta, regurgitant volume, regurgitant fraction, ERO)
• LV dimensions (LVEDD, LVESD) and function (LVEF)
• Pulmonary pressures and Qp:Qs ratio
• ASD rim measurements if percutaneous closure considered